New treatment option for people with gastrointestinal cancer

12 Oct 2017
NICE

More people will be able to receive regorafenib now that NICE has said it should move out of the Cancer Drugs Fund (CDF) and into routine NHS funding.

Please click here to read the 'NICE' news article in full